Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Невропатическая боль при сахарном диабете: причины, диагностика и обзор международных рекомендаций и алгоритмов лечения
Гурьева1,2 И.В., Давыдов3 О.С. Невропатическая боль при сахарном диабете: причины, диагностика и обзор международных рекомендаций и алгоритмов лечения. Consilium Medicum. 2013; 15 (4): 14–20.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Дедов И.И. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 5-е изд. Прил. к журн. Сахарный диабет. 2011; 3: 40–2.
2. Maser RE, Steenkiste AR, Dorman JS et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456–61.
3. Boulton AJ, Vinik AI, Arezzo JC et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28 (4): 956–62.
4. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47: 123–8.
5. Callaghan ВС, Cheng НТ, Stables СL et al. Diabetic neuropathy: clinical manifestations and current treatments Lancet Neurology 2012; 11: 521–34.
6. Cтроков И.А. Диабетическая невропатия. В кн.: Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. М.: ГЭОТАР-Медиа, 2011; с. 506–30.
7. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 2002; 18: 343–9.
8. Kapur D. Neuropathic pain and diabetes. Diabetes Metab Res Rev 2003; 19: S9–15.
9. Breivik H, Collett B, Ventafridda V et al. Survey of Chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10 (4): 287–333.
10. Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630–5.
11. Tesfaye S, Boulton AJM, Dyck PJ et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity and Treatments Diabetes care 2010; 33 (10): 2285–93.
12. Яхно Н.Н., Кукушкин М.Л., Давыдов О.С. и др. Результаты Российского эпидемиологического исследования распространенности нейропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу. Боль. 2008; 3 (20): 24–32.
13. Daousi C, MacFarlane IA, Woodward A et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976–82.
14. Van Acker K, Bouhassira D, De Bacquer D et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009; 35: 206–13.
15. Barrett AM, Lucero MA, Le T et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007; 8 (Suppl. 2): S50–62.
16. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 2007.
17. Кукушкин М.Л., Подчуфарова Е.В., Яхно Н.Н. Физиология и патофизиология боли. В кн.: Боль (практическое руководство для врачей). Под ред. Н.Н.Яхно, М.Л.Кукушкина, М.: РАМН, 2011; с. 12–56.
18. Bennett MI, Attal N, Backonja MM et al. Using screening tools to identify neuropathic pain. Pain 2007; 127: 199–203.
19. Данилов А.Б., Давыдов О.С. Диагностические шкалы для оценки нейропатической боли. Боль. 2007; 3 (16): 11–4.
20. Ziegler D, Hanefeld M, Ruhnau KJ et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38 (12): 1425–33.
21. Ruhnau KJ, Meissner HP, Finn JR et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 1999; 16 (12): 1040–3.
22. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21 (2): 114–21.
23. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alphalipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365–70.
24. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113–23.
25. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–65.
26. Spallone V. Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle? Curr Diab Rep 2012; 12: 403–13.
27. Методические рекомендации по диагностике и лечению нейропатической боли. Под ред. акад. РАМН Н.Н.Яхно, М.: РАМН, 2008.
28. http://www.vidal.ru/poisk_preparatov/act_59.htm
29. http://www.vidal.ru/poisk_preparatov/cymbalta~22246.htm
30. Lesser H, Sharma U, LaMoreaux L et al. Pregabalin relieves symptoms of painful diabetic neuropathy randomized control trial. Neurology 2004; 63 (11): 2104–10.
31. Ritcher RW, Portenoy R, Sharma U et al. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. Pain 2005; 6 (4): 235–60.
32. Rosenstock J, Truchman M, LaMoreaux. Pregabalin for the treatment of painful diabetic peripheral neuropathy. A double-blind placebo-controlled trial. Pain 2004; 110: 628–38.
33. D’Urso De Cruz E et al. Long term treatment of DPN and PHN with pregabalin in treatment-resistant patients poster presented at ADA 2005.
34. http://www.vidal.ru/poisk_preparatov/lyrica.htm
35. http://www.vidal.ru/poisk_preparatov/act_450.htm
36. http://www.vidal.ru/poisk_preparatov/act_171.htm
37. http://www.vidal.ru/poisk_preparatov/act_1068.htm
38. http://www.vidal.ru/poisk_preparatov/versatis.htm
39. Baron R, Mayoral V, Leijon G et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009; 25 (7): 1677–87.
40. Jensen TS, Backonja MM, Hernandez Jimenez S et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006; 3: 108–19.
41. Dworkin RH, O’Connor AB, Audette J et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85 (Suppl. 3): S3–14.
2. Maser RE, Steenkiste AR, Dorman JS et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456–61.
3. Boulton AJ, Vinik AI, Arezzo JC et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28 (4): 956–62.
4. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47: 123–8.
5. Callaghan ВС, Cheng НТ, Stables СL et al. Diabetic neuropathy: clinical manifestations and current treatments Lancet Neurology 2012; 11: 521–34.
6. Cтроков И.А. Диабетическая невропатия. В кн.: Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. М.: ГЭОТАР-Медиа, 2011; с. 506–30.
7. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 2002; 18: 343–9.
8. Kapur D. Neuropathic pain and diabetes. Diabetes Metab Res Rev 2003; 19: S9–15.
9. Breivik H, Collett B, Ventafridda V et al. Survey of Chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10 (4): 287–333.
10. Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630–5.
11. Tesfaye S, Boulton AJM, Dyck PJ et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity and Treatments Diabetes care 2010; 33 (10): 2285–93.
12. Яхно Н.Н., Кукушкин М.Л., Давыдов О.С. и др. Результаты Российского эпидемиологического исследования распространенности нейропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу. Боль. 2008; 3 (20): 24–32.
13. Daousi C, MacFarlane IA, Woodward A et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976–82.
14. Van Acker K, Bouhassira D, De Bacquer D et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009; 35: 206–13.
15. Barrett AM, Lucero MA, Le T et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007; 8 (Suppl. 2): S50–62.
16. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 2007.
17. Кукушкин М.Л., Подчуфарова Е.В., Яхно Н.Н. Физиология и патофизиология боли. В кн.: Боль (практическое руководство для врачей). Под ред. Н.Н.Яхно, М.Л.Кукушкина, М.: РАМН, 2011; с. 12–56.
18. Bennett MI, Attal N, Backonja MM et al. Using screening tools to identify neuropathic pain. Pain 2007; 127: 199–203.
19. Данилов А.Б., Давыдов О.С. Диагностические шкалы для оценки нейропатической боли. Боль. 2007; 3 (16): 11–4.
20. Ziegler D, Hanefeld M, Ruhnau KJ et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38 (12): 1425–33.
21. Ruhnau KJ, Meissner HP, Finn JR et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 1999; 16 (12): 1040–3.
22. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21 (2): 114–21.
23. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alphalipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365–70.
24. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113–23.
25. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–65.
26. Spallone V. Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle? Curr Diab Rep 2012; 12: 403–13.
27. Методические рекомендации по диагностике и лечению нейропатической боли. Под ред. акад. РАМН Н.Н.Яхно, М.: РАМН, 2008.
28. http://www.vidal.ru/poisk_preparatov/act_59.htm
29. http://www.vidal.ru/poisk_preparatov/cymbalta~22246.htm
30. Lesser H, Sharma U, LaMoreaux L et al. Pregabalin relieves symptoms of painful diabetic neuropathy randomized control trial. Neurology 2004; 63 (11): 2104–10.
31. Ritcher RW, Portenoy R, Sharma U et al. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. Pain 2005; 6 (4): 235–60.
32. Rosenstock J, Truchman M, LaMoreaux. Pregabalin for the treatment of painful diabetic peripheral neuropathy. A double-blind placebo-controlled trial. Pain 2004; 110: 628–38.
33. D’Urso De Cruz E et al. Long term treatment of DPN and PHN with pregabalin in treatment-resistant patients poster presented at ADA 2005.
34. http://www.vidal.ru/poisk_preparatov/lyrica.htm
35. http://www.vidal.ru/poisk_preparatov/act_450.htm
36. http://www.vidal.ru/poisk_preparatov/act_171.htm
37. http://www.vidal.ru/poisk_preparatov/act_1068.htm
38. http://www.vidal.ru/poisk_preparatov/versatis.htm
39. Baron R, Mayoral V, Leijon G et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009; 25 (7): 1677–87.
40. Jensen TS, Backonja MM, Hernandez Jimenez S et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006; 3: 108–19.
41. Dworkin RH, O’Connor AB, Audette J et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85 (Suppl. 3): S3–14.
Авторы
И.В.Гурьева1,2, О.С.Давыдов3
1. ФГБУ Федеральное бюро медико-социальной экспертизы, Москва;
2. ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ;
3. Компания «Пфайзер Эйч. Си. Пи. Корпорэйшн», США
1. ФГБУ Федеральное бюро медико-социальной экспертизы, Москва;
2. ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ;
3. Компания «Пфайзер Эйч. Си. Пи. Корпорэйшн», США
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.